Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Wen Wang, Xin Yang, Chong Li, Yandong Li, Haibo Wang & Xue Han. (2022) Immunogenic Cell Death (ICD) of Murine H22 Cells Induced by Lentinan. Nutrition and Cancer 74:2, pages 640-649.
Read now
Read now
Qiaohong Geng, Sagar O. Rohondia, Harras J. Khan, Peifu Jiao & Q. Ping Dou. (2020) Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019). Expert Opinion on Therapeutic Patents 30:9, pages 677-694.
Read now
Read now
Florent Amatore, Laurent Gorvel & Daniel Olive. (2020) Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy. Expert Opinion on Biological Therapy 20:2, pages 141-150.
Read now
Read now
Martin Perez-Santos, Maricruz Anaya-Ruiz, Jorge Cebada, Cindy Bandala, Gerardo Landeta, Patricia Martínez-Morales & Nemesio Villa-Ruano. (2019) LAG-3 antagonists by cancer treatment: a patent review. Expert Opinion on Therapeutic Patents 29:8, pages 643-651.
Read now
Read now
Florent Amatore, Laurent Gorvel & Daniel Olive. (2018) Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy. Expert Opinion on Therapeutic Targets 22:4, pages 343-351.
Read now
Read now
Luigi Cari, Giuseppe Nocentini, Graziella Migliorati & Carlo Riccardi. (2018) Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis. OncoImmunology 7:2.
Read now
Read now
Xiangjun Kong, Qianru Zhang, Yunfeng Lai, Hao Hu, Xin Chen & Yuanjia Hu. (2018) Global patent landscape of programmed cell death 1: implications of the rapid expansion. Expert Opinion on Therapeutic Patents 28:1, pages 69-80.
Read now
Read now
Chia-Lin Pan & Feng-Chi Chen. (2017) Patent trend and competitive analysis of cancer immunotherapy in the United States. Human Vaccines & Immunotherapeutics 13:11, pages 2583-2593.
Read now
Read now
Articles from other publishers (36)
Shenglun Li, Yuduo Guo, Weihai Ning, Yujia Chen, Jiacheng Xu, Chao Zhao, Jun Wang, Yanming Qu, Mingshan Zhang, Pengju Wang, Yaohe Wang, Shengdian Wang & Hongwei Zhang. (2024) Oncolytic virus Ad-TD-nsIL-12 inhibits glioma growth and reprograms the tumor immune microenvironment. Life Sciences 336, pages 122254.
Crossref
Crossref
Man Wang, Fei Yu & Peifeng Li. (2023) Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications. Frontiers in Immunology 14.
Crossref
Crossref
Shilpi Singh, Bindu Kumari, Sonal Sinha, Gireesh Kumar Singh, Suaib Lqman & Dhananjay Kumar Singh. 2023. Probiotics in Anticancer Immunity. Probiotics in Anticancer Immunity
162
188
.
Yan He, Nannan Cao, Yanan Tian, Xuelin Wang, Qiaohong Xiao, Xiaojuan Tang, Jiaolong Huang, Tingting Zhu, Chunhui Hu, Ying Zhang, Jie Deng, Han Yu & Peng Duan. (2023) Development and validation of two redox-related genes associated with prognosis and immune microenvironment in endometrial carcinoma. Mathematical Biosciences and Engineering 20:6, pages 10339-10357.
Crossref
Crossref
Tian-You Cheng, Ya-Juan Liu, Hong Yan, Yi-Bo Xi, Li-Qiang Duan, Yang Wang, Tian-Tian Zhang, Yin-Min Gu, Xiao-Dong Wang, Chang-Xin Wu & Shan Gao. (2022) Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2. Cells 11:24, pages 4021.
Crossref
Crossref
Ya Gao, Ming Liu, Lun Li, Junhua Zhang, Fujian Song & JinHui Tian. (2022) Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer. Cochrane Database of Systematic Reviews 2022:9.
Crossref
Crossref
María Belén Palma, Diana Tronik-Le Roux, Guadalupe Amín, Sheila Castañeda, Alan M. Möbbs, María Agustina Scarafia, Alejandro La Greca, Marina Daouya, Isabelle Poras, Ana María Inda, Lucía N. Moro, Edgardo D. Carosella, Marcela N. García & Santiago G. Miriuka. (2021) HLA-G gene editing in tumor cell lines as a novel alternative in cancer immunotherapy. Scientific Reports 11:1.
Crossref
Crossref
Lincheng Fang, Jiping Tian, Kaixuan Zhang, Xiaoyi Zhang, Yingqiao Liu, Zhibo Cheng, Jinpei Zhou & Huibin Zhang. (2021) Discovery of 1,3,4-oxadiazole derivatives as potential antitumor agents inhibiting the programmed cell death-1/programmed cell death-ligand 1 interaction. Bioorganic & Medicinal Chemistry 46, pages 116370.
Crossref
Crossref
Patricia Sanz-Segura, Paula García-Cámara, Eva Fernández-Bonilla, José Miguel Arbonés-Mainar & Vanesa Bernal Monterde. (2021) Efectos adversos inmunomediados gastrointestinales y hepáticos inducidos por los inhibidores del punto de control inmunitario: estudio descriptivo observacional. Gastroenterología y Hepatología 44:4, pages 261-268.
Crossref
Crossref
Patricia Sanz-Segura, Paula García-Cámara, Eva Fernández-Bonilla, José Miguel Arbonés-Mainar & Vanesa Bernal Monterde. (2021) Gastrointestinal and liver immune-related adverse effects induced by immune checkpoint inhibitors: A descriptive observational study. Gastroenterología y Hepatología (English Edition) 44:4, pages 261-268.
Crossref
Crossref
Yang Yang, Ke Wang, Hao Chen & Zhiqiang Feng. (2021) Design, synthesis, evaluation, and SAR of 4-phenylindoline derivatives, a novel class of small-molecule inhibitors of the programmed cell death-1/ programmed cell death-ligand 1 (PD-1/PD-L1) interaction. European Journal of Medicinal Chemistry 211, pages 113001.
Crossref
Crossref
Kai-Liang Ma, Shi-Hui Dong, Hang-Ying Li, Wen-Jun Wei, Yong-Qiang Tu & Kun Gao. (2020) Cytochalasins from Xylaria sp. CFL5, an Endophytic Fungus of Cephalotaxus fortunei. Natural Products and Bioprospecting 11:1, pages 87-98.
Crossref
Crossref
Ayse Basak Engin & Atilla Engin. 2021. Protein Kinase-mediated Decisions Between Life and Death. Protein Kinase-mediated Decisions Between Life and Death
339
356
.
Gilson P. Dorneles, Igor M. da Silva, Maeli Andressa Santos, Viviane R. Elsner, Simone G. Fonseca, Alessandra Peres & Pedro R. T. Romão. (2020) Immunoregulation induced by autologous serum collected after acute exercise in obese men: a randomized cross-over trial. Scientific Reports 10:1.
Crossref
Crossref
Flóra John, Otto Muzik, Sandeep Mittal & Csaba Juhász. (2019) Fluorine-18-Labeled PET Radiotracers for Imaging Tryptophan Uptake and Metabolism: a Systematic Review. Molecular Imaging and Biology 22:4, pages 805-819.
Crossref
Crossref
Omid Kooshkaki, Afshin Derakhshani, Negar Hosseinkhani, Mitra Torabi, Sahar Safaei, Oronzo Brunetti, Vito Racanelli, Nicola Silvestris & Behzad Baradaran. (2020) Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials. International Journal of Molecular Sciences 21:12, pages 4427.
Crossref
Crossref
Lucía Figueroa-Protti, Rebeca Soto-Molinari, Melany Calderón-Osorno, Javier Mora & Warner Alpízar-Alpízar. (2019) Gastric Cancer in the Era of Immune Checkpoint Blockade. Journal of Oncology 2019, pages 1-11.
Crossref
Crossref
Lingdi Zhao, Yonghao Yang, Wei Li, Tiepeng Li, Lu Han, Hongwei Lin & Quanli Gao. (2019) Pseudoprogression: an indicator for cure in combined immunotherapy?. Immunotherapy 11:13, pages 1087-1093.
Crossref
Crossref
Mu-Yang Huang, Xiao-Ming Jiang, Yu-Lian Xu, Luo-Wei Yuan, Yu-Chi Chen, Guozhen Cui, Run-Yue Huang, Bo Liu, Yitao Wang, Xiuping Chen & Jin-Jian Lu. (2019) Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells. Food and Chemical Toxicology 131, pages 110537.
Crossref
Crossref
Michael S. Hughes, Hui Zheng, Leyre Zubiri, Gabriel E. Molina, Steven T. Chen, Meghan J. Mooradian, Ian M. Allen, Kerry L. Reynolds & Michael Dougan. (2019) Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control. Cancer Medicine 8:11, pages 4986-4999.
Crossref
Crossref
Ya Gao, Shuzhen Shi, Wenjuan Ma, Ji Chen, Yitong Cai, Long Ge, Lun Li, Jiarui Wu & Jinhui Tian. (2019) Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer. International Immunopharmacology 72, pages 374-384.
Crossref
Crossref
Suheil Albert Atallah-Yunes, Anis John Kadado, Gregory P. Kaufman & Jaime Hernandez-Montfort. (2019) Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases. Journal of Cancer Research and Clinical Oncology 145:6, pages 1527-1557.
Crossref
Crossref
Yanwen Zhong, Xuanyi Li, Hequan Yao & Kejiang Lin. (2019) The Characteristics of PD-L1 Inhibitors, from Peptides to Small Molecules. Molecules 24:10, pages 1940.
Crossref
Crossref
Xueping Yu, Yijuan Zheng, Richeng Mao, Zhijun Su & Jiming Zhang. (2019) BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection. Frontiers in Immunology 10.
Crossref
Crossref
Qingfang Zhao, Liang Cao, Lulu Guan, Liangyu Bie, Saiqi Wang, Bojian Xie, Xiaobing Chen, Xiaokun Shen & Feiling Cao. (2019) Immunotherapy for gastric cancer: dilemmas and prospect. Briefings in Functional Genomics 18:2, pages 107-112.
Crossref
Crossref
Maria E. Joosse, Iris Nederlof, Lucy S.K. Walker & Janneke N. Samsom. (2019) Tipping the balance: inhibitory checkpoints in intestinal homeostasis. Mucosal Immunology 12:1, pages 21-35.
Crossref
Crossref
Jai Woong Seo, Richard Tavaré, Lisa M. Mahakian, Matthew T. Silvestrini, Sarah Tam, Elizabeth S. Ingham, Felix B. Salazar, Alexander D. Borowsky, Anna M. Wu & Katherine W. Ferrara. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clinical Cancer Research 24:20, pages 4976-4987.
Crossref
Crossref
Miwa Fukuda, Tomomi Sasaki, Tomoko Hashimoto, Hiroyuki Miyachi, Minoru Waki, Akira Asai, Osamu Takikawa, Osamu Ohno & Kenji Matsuno. (2018) Cyclic analogue of S-benzylisothiourea that suppresses kynurenine production without inhibiting indoleamine 2,3-dioxygenase activity. Bioorganic & Medicinal Chemistry Letters 28:17, pages 2846-2849.
Crossref
Crossref
Ruomeng Qiu & Yonghui Wang. (2018) Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy. Journal of Medicinal Chemistry 61:14, pages 5794-5804.
Crossref
Crossref
Qiaohong Wang, Jingze Gao & Xia Wu. (2018) Pseudoprogression and hyperprogression after checkpoint blockade. International Immunopharmacology 58, pages 125-135.
Crossref
Crossref
Yuichi Imai, Kosei Hasegawa, Hirokazu Matsushita, Nao Fujieda, Sho Sato, Etsuko Miyagi, Kazuhiro Kakimi & Keiichi Fujiwara. (2018) Expression of multiple immune checkpoint molecules on T�cells in malignant ascites from epithelial ovarian carcinoma. Oncology Letters.
Crossref
Crossref
Wei Yang, Søren Berg Padkjær, Jishu Wang, Zhe Sun, Bing Shan, Li Yang, Haibin Chen, Lishan Kang, Dennis Madsen, Xun Li, Chenxi Shen, Bingke Yu, Haisun Zhu, Tzu-Yuan Chao, Zhuoxiao Cao, Dapeng Li, Wei Liu, Yanping Du, Jinjing Xu, Dongxia Hao, Fengting Xu, Lujia Peng, Tengkun Li, Lin Wang, Lin Li, Haimei Xing, Di Liu, Zibing Liu, Zhishuang Guan, Wan Wang, Hong Cheng, Henrik Østergaard, Chihchuan Chang, Zhiru Yang, Esper Boel & Jing Su. (2017) Construction of a versatile expression library for all human single-pass transmembrane proteins for receptor pairings by high throughput screening. Journal of Biotechnology 260, pages 18-30.
Crossref
Crossref
Natan Stein, Pinchas Tsukerman & Ofer Mandelboim. (2017) The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodies. Human Antibodies 25:3-4, pages 111-119.
Crossref
Crossref
Virginia Bayer, Beau Amaya, Diane Baniewicz, Colleen Callahan, Lisa Marsh & Asia McCoy. (2017) Cancer Immunotherapy: An Evidence-Based Overview and Implications for Practice. Clinical Journal of Oncology Nursing 21:2, pages 13-21.
Crossref
Crossref
Sharon K. Michelhaugh, Otto Muzik, Anthony R. Guastella, Neil V. Klinger, Lisa A. Polin, Hancheng Cai, Yangchun Xin, Thomas J. Mangner, Shaohui Zhang, Csaba Juhász & Sandeep Mittal. (2017)
Assessment of Tryptophan Uptake and Kinetics Using 1-(2-
18
F-Fluoroethyl)-l-Tryptophan and α-
11
C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts
. Journal of Nuclear Medicine 58:2, pages 208-213.
Crossref
Crossref
Don M. BensonJrJr. (2016) Checkpoint inhibition in myeloma. Hematology 2016:1, pages 528-533.
Crossref
Crossref